Flinn.ai
We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
Flinn.ai
We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
TL;DR
Sector: AI-driven SaaS for MedTech compliance (PMS, regulatory monitoring, literature evaluation)
Founded: December 2022
HQ: Vienna, Austria (offices in Berlin and Paris)
Employees: ≈45
Known investors: Cherry Ventures (lead), Speedinvest, SquareOne; public FFG support; 20+ angels
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
MedTech regulatory compliance, post-market surveillance, quality management and documentation for medical device manufacturers.
Founded
2022
Industry
Software Development
Funding Track Record
nearly €10 million (total disclosed)
Other institutional backers include Speedinvest and SquareOne (pre. Paua Ventures); company also reports public support from FFG Austria and backing from 20+ business angels.
Investor Signal
“Seed round led by Cherry Ventures with participation from Speedinvest and SquareOne; public FFG support and 20+ angel investors”